EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

KPS Corporation (256940) fair value: what the stock is really worth

As of Oct 2, 2026: fair value of KPS Corporation KRW 847, price KRW 6,970, upside -87.9%, quality 23 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? No
  3. Add to watchlist

Consumer Defensive · KR · ISIN KR7256940008

KC Thin data Oct 4, 2026

KPS Corporation

256940 · KQ

Weakest SetupStrongly overvalued and low quality.

Mixed Growth (revenue 5y +62.1 %/yr in KRW)
Moderate debt
Fair value 847.00 KRW · Strongly overvalued (−87.9%)
Quality 23/100
Loss-making · -5.6% net margin (TTM)
Negative free cash flow
Trails peers (2/9)
Narrow moat 14/100
Thin data
Structural break

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

20,950 KRW 4,235 KRW Fair Value 847.00 KRW May 2021 Oct 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 4, 2026.

How to read this chart

60‑month range 4,235 KRW – 20,950 KRW · fair‑value band 632.39 KRW – 1,019 KRW · the 6,970 KRW price screens above the 847.00 KRW fair value. Dashed = 300-day average. As of Oct 4, 2026.

Follow KPS in your weekly email

Every Wednesday you see whether KPS is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Keeps Biopharma Inc. engages in the research, development, production, and sale of mechanical equipment for manufacturing flat panel displays in South Korea, China, and internationally. It offers OLED equipment, inspection technologies, camera modules, precision systems, and TSP/solar products.

Show more

Keeps Biopharma Inc. engages in the research, development, production, and sale of mechanical equipment for manufacturing flat panel displays in South Korea, China, and internationally. It offers OLED equipment, inspection technologies, camera modules, precision systems, and TSP/solar products. The company is also involved in bio research and development business; waste battery recycling; and other non-ferrous metal smelting, refining, and alloy manufacturing. The company was formerly known as KPS Corporation and changed its name to Keeps Biopharma Inc. in April 2025. Keeps Biopharma Inc. was founded in 2000 and is headquartered in Hwaseong-si, South Korea.

Stock analysis

KPS Corporation (256940) currently trades at 6,970 KRW, while our model-based Fair Value estimate is 847.00 KRW, 87.9% below the price, so the stock looks overvalued today.

Show more

Valuation

Bull case: the Multiples group reads highest at a median of 4,005 KRW per share, and 0 of the 6 models we run sit above the 6,970 KRW price.

Bear case: the Earnings-Based group reads lowest at 969.84 KRW, and 6 of the 6 models stay below the price. Evidence for this calculation is low.

Scenario range: 632.39 KRW (bear) to 1,019 KRW (bull), the price of 6,970 KRW sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 23/100 (below-average quality), in the Consumer Defensive sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

KPS Corporation reported revenue of 170B KRW in FY2025 versus 4.3B KRW in FY2021, a compound +151.4%/yr. Reported net income was −9.8B KRW in FY2025.

Key figures

Market cap 140B KRW (≈ $104M) · P/S ratio 0.63 · Net margin −5.8% · Return on equity −15.6% · Return on assets (EBIT) −1.7% · Operating margin −3.2% · Revenue (TTM) 220B KRW · Revenue growth (YoY) +72.8%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 32 out of 100 (medium confidence).

What moves the price

The share trades about 44% below its 52-week high and 31% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Consumer Defensive peers we cover trades at −29% fair-value upside, at −88%, 256940 screens richer than that median.

Fair Value models

Bear 632.39 KRW Fair Value 847.00 KRW Bull 1,019 KRW
Price 6,970 KRW · Upside -87.9%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
EPV 730.90 KRW 969.84 KRW 1,164 KRW 74
ROIC Compounder 730.90 KRW 969.84 KRW 1,164 KRW 70
EV/EBITDA 3,939 KRW 5,672 KRW 7,405 KRW 67
All 6 models by family
Earnings-Based
EPV 730.90 KRW 969.84 KRW 1,164 KRW 74
Multiples
EV/EBIT 2,689 KRW 4,005 KRW 5,322 KRW 65
EV/EBITDA 3,939 KRW 5,672 KRW 7,405 KRW 67
EV/Revenue 1,558 KRW 2,766 KRW 3,974 KRW 52
Asset-Based
NCAV (Graham) 1,544 KRW 2,069 KRW 3,088 KRW 54
Economic Profit
ROIC Compounder 730.90 KRW 969.84 KRW 1,164 KRW 70

Open the full fair value analysis →

Notify me when 256940 reaches fair value

Put 256940 on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 23/100

Of which business quality 26 · Market factors (momentum, volatility) 27

Profitability 17
Margins and returns on capital today
Quality Growth 46
Are margins and returns improving?
Cashflow 23
Earnings quality: real cash, not paper profit
Fin. Strength 21
Balance sheet, leverage, solvency risk
Investment 25
Disciplined investing over empire-building
Low Volatility 30
Calm price path (market factor)
Momentum 34
Price trend over the last 3–12 months (market factor)
52W Momentum 12
Distance to the 52-week high (market factor)
Net Issuance 34
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 30/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+33.4%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+126.6%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+62.1%
Start year 2020 (pandemic). Over 10 years: +34.9% a year
Revenue growth 10 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+34.9%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−6.9% (2019) → 4.9% (2024)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

256940 screens overvalued: fair value 88% below the price. Compare with Colgate-Palmolive Company →

Compare KPS Corporation with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Household & Personal Products · 242 stocks

Beats the industry median on 2/8 measures
Overall it trails its industry peers.
Valuation
Quality Score 23 · Bottom 25%
Fair Value upside −87.8% · Bottom 25%
Profitability
Return on assets −0.2% · Bottom 25%
Net margin (TTM) −5.6% · Bottom 25%
Operating margin (TTM) −3.2% · Bottom 25%
Growth and dividend
Revenue growth 72.8% · Top 25%
Balance sheet
Debt / equity 0.76× · Highest 25%

Valuation Multiplesvs Household & Personal Products median · lower = cheaper

EV/EBITDA 5.3× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 31
FUTURE (revenue growth)100 · sector 19
PAST (return on equity)0 · sector 29
HEALTH (low debt)62 · sector 98
DIVIDEND (yield)0 · sector 54

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Household & Personal Products stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Colgate-Palmolive Company CL $84.26 $56.16 −33%
Hindustan Unilever Limited HINDUNILVR ₹1,836 ₹775.25 −58%
Kenvue Inc KVUE $17.80 $12.72 −29%
The Estée Lauder Companies Inc EL $90.19 $44.21 −51%
Kimberly-Clark Corporation KMB $94.36 $83.77 −11%
Henkel AG HEN €66.35 €82.61 +25%
Church & Dwight Co CHD $94.31 $65.04 −31%
Beiersdorf Aktiengesellschaft, BEI €75.40 €69.09 −8%
Puig Brands, S.A PUIG €17.84 €24.28 +36%
Marico Limited MARICO ₹781.35 ₹493.84 −37%

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "KPS Corporation Fair Value". https://www.fairvalue-calculator.com/stock/256940

Frequently asked questions

Is KPS Corporation (256940) overvalued or undervalued?
As of Oct 4, 2026, our model estimates a fair value of 847.00 KRW versus a price of 6,970 KRW, about −88% upside (overvalued).
What is the fair value of 256940?
Our model-based fair value for KPS Corporation is 847.00 KRW (as of Oct 4, 2026), built from audited fundamentals. The current price: 6,970 KRW.
What is the quality score of 256940?
KPS Corporation has a Quality Score of 23/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for KPS Corporation (256940)?
Our model-based price target is the fair value of 847.00 KRW (as of Oct 4, 2026) from 6 valuation models. Cautious scenario 632.39 KRW, optimistic scenario 1,019 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the KPS Corporation stock forecast for 2026?
Our models put fair value at 847.00 KRW, about −88% upside versus a price of 6,970 KRW (overvalued). Cautious scenario 632.39 KRW, optimistic scenario 1,019 KRW. The calculation is refreshed regularly with new filings.
What is the revenue of KPS Corporation (256940)?
KPS Corporation reported trailing-twelve-month revenue of about 220B KRW (latest available figure, as of Oct 4, 2026).
What is the intrinsic value of KPS Corporation (256940)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For KPS Corporation it is 847.00 KRW per share (as of Oct 4, 2026), against a price of 6,970 KRW. It is the blended result of 6 valuation models (cash flow, earnings, asset, dividend).
Is KPS Corporation stock overvalued or undervalued in 2026?
As of Oct 4, 2026, 256940 trades above its calculated fair value: price 6,970 KRW, fair value 847.00 KRW, a gap of about −88% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 256940?
No. The price is what the market pays today (6,970 KRW); the fair value is what the company's own numbers justify (847.00 KRW). For KPS Corporation the two are 6,123 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is KPS Corporation worth?
The market values KPS Corporation at about 140B KRW (market capitalisation, as of Oct 4, 2026). Per share that is 6,970 KRW; our models calculate a fair value of 847.00 KRW per share.
What do the bullish and bearish scenarios say about 256940?
Our models span a range for KPS Corporation: cautious scenario 632.39 KRW, base 847.00 KRW, optimistic 1,019 KRW per share (as of Oct 4, 2026, price 6,970 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of KPS Corporation (256940)?
Balance-sheet figures for KPS Corporation (as of Oct 4, 2026): return on equity −15.6%, debt of 0.76 per unit of equity. They feed the Quality Score of 23/100, which measures business quality independently of the share price.
How far is 256940 from its 52-week high?
KPS Corporation trades at 6,970 KRW, about 44% below its 52-week high of 12,450 KRW and 31% above the low of 5,320 KRW (as of Oct 2, 2026). Distance from the high says nothing about value: that is what the fair value of 847.00 KRW is for.
Which stocks are comparable to KPS Corporation?
From the same area (Consumer Defensive) we also value Colgate-Palmolive Company, Hindustan Unilever Limited, Kenvue Inc, The Estée Lauder Companies Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is KPS Corporation stock attractive at the current price?
The data as of Oct 4, 2026: price 6,970 KRW, calculated fair value 847.00 KRW (−88%), Quality Score 23/100, from 6 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 256940 calculated?
We run KPS Corporation through 6 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 847.00 KRW, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 15.0 % above its aggregate fair value. KPS Corporation itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of KPS Corporation (256940)?
The closing price on Oct 2, 2026 was 6,970 KRW. Our model-based fair value is 847.00 KRW, about −88% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with KPS Corporation right now?
The price sits above even our optimistic bull case (1,019 KRW). The favourable scenario is already priced in. Weak quality (23/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.

Key figures of KPS Corporation

How large is the market capitalisation of KPS Corporation (256940)?
The market capitalisation of KPS Corporation is 140B KRW (≈ $104M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of KPS Corporation (256940)?
The price-to-sales ratio of KPS Corporation is 0.63 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the net margin of KPS Corporation (256940)?
The net margin of KPS Corporation is −5.8% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of KPS Corporation (256940)?
The return on equity (ROE) of KPS Corporation is −15.6% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of KPS Corporation (256940)?
On an EBIT basis the return on assets of KPS Corporation is −1.7% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of KPS Corporation (256940)?
The operating margin of KPS Corporation is −3.2% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at KPS Corporation (256940)?
Revenue at KPS Corporation is growing +72.8% versus a year earlier (3y avg +127%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at KPS Corporation (256940)?
Earnings per share at KPS Corporation are growing −85.9% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does KPS Corporation (256940) generate?
The free cash flow of KPS Corporation is −49.8B KRW (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does KPS Corporation (256940) carry?
The net debt of KPS Corporation is 70.1B KRW (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch KPS Corporation in the live analysis

One click puts KPS Corporation on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.